Superficial Fungal Infections
Peter Mayser
Clinic of Dermatology, Allergology and Venereology, Justus Liebig University (UKGM), Giessen, Germany
Search for more papers by this authorYvonne Gräser
The National Reference Laboratory for Dermatophytes, Universitätsmedizin – Charité, Institute of Microbiology and Hygiene, Berlin, Germany
Search for more papers by this authorPeter Mayser
Clinic of Dermatology, Allergology and Venereology, Justus Liebig University (UKGM), Giessen, Germany
Search for more papers by this authorYvonne Gräser
The National Reference Laboratory for Dermatophytes, Universitätsmedizin – Charité, Institute of Microbiology and Hygiene, Berlin, Germany
Search for more papers by this authorPeter Hoeger
Search for more papers by this authorVeronica Kinsler
Search for more papers by this authorAlbert Yan
Search for more papers by this authorJohn Harper
Search for more papers by this authorArnold Oranje
Search for more papers by this authorChristine Bodemer
Search for more papers by this authorMargarita Larralde
Search for more papers by this authorVibhu Mendiratta
Search for more papers by this authorDiana Purvis
Search for more papers by this authorSummary
Superficial mycoses are among the most common skin infections. Molecular methods can accelerate diagnosis. In childhood, tinea capitis, especially caused by anthropophilic dermatophytes, is of rising importance. Oral therapy is essential. Index cases due to T. tonsurans, T. violaceum and M. audouinii warrant screening of all family members and close contacts and treatment of asymptomatic carriers. Onychomycosis, although uncommon in children, increases with age. Risk factors are sporting activities and infected parents. Recalcitrant candidosis may be indicative of immune deficiency. Among children in the tropics, pityriasis versicolor is not an uncommon disease. Furthermore Malassezia yeasts seem to be associated mainly with the head, neck and face types of atopic eczema/dermatitis syndrome, corresponding to the numerous sebaceous glands found in this region, but it remains to be clarified whether this is also applicable to children.
References
- Seeliger HPR. The discovery of Achorion schoenleinii. Mykosen 1985; 28: 161–82.
- Schoenlein JL. Zur Pathologie der Impetigines. Arch Anat Phys Wiss Medical 1839: 82.
- Remak R. Diagnostische und Pathogenetische Unterschungen in der Klinik des Geh. Raths Dr Schoenlein auf dessen Veranlassung an-gestellt und mit Benutzung anderweitiger Beobachtungen veröffent-licht. Berlin: A. Hirschwald, 1845: 242.
- Gruby D. Sur les mycodermes que constituent la teigne faveuse. CR Acad Sci (Paris) 1841; 13: 309–12.
- Sabouraud R. Les Teignes. Paris: Masson, 1910.
-
Emmons CW. Dermatophytes: natural groupings based on the form of spores and accessory organs. Arch Dermatol Syph 1934; 30: 337–62.
10.1001/archderm.1934.01460150003001 Google Scholar
- Stockdale PM, MacKenzie DWR, Austwick PKC. Arthroderma simii sp. nov.: the perfect state of Trichophyton simii (pinoy) comb. nov. Sabouraudia 1965; 4: 112–23.
- Gräser Y, Scott J, Summerbell R. The new species concept in dermatophytes – a polyphasic approach. Mycopathologia 2008; 166: 239–56.
- de Hoog GS, Dukik K, Monod M et al. Towards a novel multilocus phylogenetic taxonomy for the dermatophytes. Mycopathologia 2017; 182: 5–31.
- Gentles JC. Experimental ringworm in guinea pigs: oral treatment with griseofulvin. Nature (Lond) 1958; 182: 476–7.
- Prochacki H. Mycological flora isolated from people in Poland. Mycopathol Mycol Appl 1970; 40: 65–72.
- Sinski JT, Flouras K. A survey of dermatophytes isolated from human patients in the United States 1979–1981 with chronological listings of worldwide incidence of five dermatophytes often isolated in the United States. Mycopathologia 1984; 85: 97–120.
- Verhagen AR. Distribution of dermatophytes causing tinea capitis in Africa. Trop Geogr Med 1974; 26: 101–20.
- Nenoff P, Krüger C, Ginter-Hanselmayer G, Tietz HJ. Mycology - an update. Part 1: Dermatomycoses: causative agents, epidemiology and pathogenesis. J Dtsch Dermatol Ges 2014; 12: 188–209.
- Bronson DM, Desai DR, Barskey S et al. An epidemic of infection with Trichophyton tonsurans revealed in a 20-year survey of fungal infections in Chicago. J Am Acad Dermatol 1983; 8: 322–30.
- Foster KW, Ghannoum MA, Elewski BE. Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002. J Am Acad Dermatol 2004; 50: 748–52.
- Rogers M, Muir D, Pritchard R. Increasing importance of Trichophyton tonsurans in childhood tinea in New South Wales. Australas J Dermatol 1993; 34: 5–8.
- Hay RJ, Robles W, Midgley G et al., on behalf of the European Confederation of Medical Mycology Working Party on Tinea Capitis. Tinea capitis in Europe: new perspective on an old problem. J Eur Acad Dermatol Venereol 2001; 15: 229–33.
- Borman AM, Campbell CK, Fraser M et al. Analysis of the dermatophyte species isolated in the British Isles between 1980 and 2005 and review of worldwide dermatophyte trends over the last three decades. Med Mycol 2007; 45: 131–41.
- Kieliger S, Glatz M, Cozzio A, Bosshard PP.Tinea capitis and tinea faciei in the Zurich area – an 8-year survey of trends in the epidemiology and treatment patterns. J Eur Acad Dermatol Venereol. 2015; 29: 1524–9.
- Ginter-Hanselmayer G, Weger W, Ilkit M et al. Epidemiology of tinea capitis in Europe: current state and changing patterns. Mycoses 2007; 50(suppl 2): 6–13.
- Nenoff P, Uhrlaß S, Krüger C et al. Trichophyton species of Arthroderma benhamiae – a new infectious agent in dermatology. J Dtsch Dermatol Ges 2014; 12: 571–81.
- Babel DE, Baughman SA. Evaluation of adult carrier state in juvenile tinea capitis caused by Trichophyton tonsurans . J Am Acad Dermatol 1989; 21: 1209–12.
- Elewski BE. Tinea capitis: a current perspective. J Am Acad Dermatol 2000; 42: 1–20.
- White JM, Higgins EM, Fuller LC. Screening for asymptomatic carriage of Trichophyton tonsurans in household contacts of patients with tinea capitis: results of 209 patients from South London. J Eur Acad Dermatol Venereol 2007; 21: 1061–4.
- Munro-Ashman D, Clayton YM. Tinea pedis in adolescence. Proc Roy Soc Med 1962; 55: 551–4.
- Hube B, Hay R, Brasch J et al. Dermatomycoses and inflammation: The adaptive balance between growth, damage, and survival. J Mycol Med 2015; 25: e44–58.
- Kligman AM. The pathogenesis of tinea capitis due to Microsporum audouinii and M. canis . J Invest Dermatol 1952; 18: 231–46.
- Burmester A, Shelest E, Glöckner G et al. Comparative and functional genomics provide insights into the pathogenicity of dermatophytic fungi. Genome Biol 2011; 12: R7.
- Sriranganadane D, Waridel P, Salamin K et al. Identification of novel secreted proteases during extracellular proteolysis by dermatophytes at acidic pH. Proteomics 2011; 11: 4422–33.
- Staib P, Zaugg C, Mignon B et al. Differential gene expression in the pathogenic dermatophyte Arthroderma benhamiae in vitro versus infection. Microbiology 2010; 156: 884–95.
- Méhul B, Gu Z, Jomard A et al. Sub6 (Tri r 2), an onychomycosis marker revealed by proteomics analysis of Trichophyton rubrum secreted proteins in patient nail samples. J Invest Dermatol 2016; 136: 331–3.
- Woodfolk JA Allergy and dermatophytes. Clin Microbiol Rev 2005; 18: 30–43.
- Jensen JM, Pfeiffer S, Akaki T et al. Barrier function, epidermal differentiation, and human beta-defensin 2 expression in tinea corporis. J Invest Dermatol 2007; 127: 1720–7.
- Almeida SR. Immunology of dermatophytosis. Mycopathologia 2008; 166: 277–83.
- Vermout S, Tabart J, Baldo A et al. Pathogenesis of dermatophytosis. Mycopathologia 2008; 166: 267–75.
- García-Romero MT, Arenas R. New insights into genes, immunity, and the occurrence of dermatophytosis. J Invest Dermatol 2015; 135: 655–7.
- Ackerman AB. Histologic Diagnosis of Inflammatory Skin Disease. Baltimore: Williams and Wilkins, 1997.
- Capesius-Dupin C, Benaily N, Hennequin C et al. Dermatomycoses en pediatrie. J Mycol Med 1995; 5(suppl 1): 40–5.
- Monteiro CM, Ferreira JA, Goncalves HMG et al. Dermatophytosis in a newborn infant: report of a case. Med Cut Ibero-Lat Am 1991; 19: 164–6.
- Ive FA, Marks R. Tinea incognito. BMJ 1968; 3: 149–50.
- Parry EL, Fosher WS, Marks JG. Diaper dermatophytosis. Am J Dis Child 1982; 136: 273–4.
- Kearse HL, Miller OF. Tinea pedis in prepubertal children: does it occur? J Am Acad Dermatol 1988; 19: 619–22.
- English MP, Gibson MD. Studies in the epidemiology of tinea pedis. 1. Tinea pedis in school children. BMJ 1959; 1: 1442–6.
- Svejgaard E, Albrectsen B, Baastrup N. The occurrence of tinea of the feet in 15-year-old school children. Mykosen 1983; 26: 450–4.
- Terragni L, Buzzetti I, Lasagni A et al. Tinea pedis in children. Mycoses 1991; 34: 273–6.
- Reichert-Penetrat S, Contet-Andonneau N, Barbaud A et al. Epidemiology of dermatophytoses in children living in northeast France: a 5-year study. Pediatr Dermatol 2002; 19: 103–5.
- Jang KA, Chi DH, Choi JH et al. Tinea pedis in Korean children. Int J Dermatol 2000; 39: 25–7.
- Maroon MS, Miller OF. Trichophyton rubrum bullous tinea pedis in a child. Arch Dermatol 1989; 125: 1716.
- Philpot CM, Shuttleworth D. Dermatophyte onychomycosis in children. Clin Exp Dermatol 1989; 14: 203–5.
- Chang P, Logemann H. Onychomycosis in children. Int J Dermatol 1994; 33: 550–1.
- Lange M, Roszkiewicz J, Szczerkowska-Dobosz A et al. Onychomycosis is no longer a rare finding in children. Mycoses 2006; 49: 55–9.
- Bonifaz A, Saul A, Mena C et al. Dermatophyte onychomycosis in children under 2 years of age: experience of 16 cases. J Eur Acad Dermatol Venereol 2007; 21: 115–17.
- Kalter DC, Hay RJ. Onychomycosis due to Trichophyton soudanense . Clin Exp Dermatol 1988; 13: 221–7.
- Dompmartin D, Dompmartin A, Deluol AM et al. Onychomycosis and AIDS. Int J Dermatol 1990; 29: 337–9.
- Tosti A, Baran R, Piraccini BM et al. ‘Endonyx’ onychomycosis: a new modality of nail invasion by dermatophytes. Acta Dermatol Venereol 1999; 79: 52–3.
- Baran R, Hay RJ, Tosti A et al. A new classification of onychomycosis. Br J Dermatol 1998; 139: 567–71.
- Al-Fouzan AS, Nanda A. Dermatophytosis of children in Kuwait. Pediatr Dermatol 1992; 9: 27–30.
- Nicholls DSH, Midgley G. Onychomycosis caused by Trichophyton equinum . Clin Exp Dermatol 1989; 14: 464–5.
- Ilkit M, Durdu M, Karakaş M. Cutaneous id reactions: a comprehensive review of clinical manifestations, epidemiology, etiology, and management. Crit Rev Microbiol 2012; 38: 191–212.
- Nenoff P, Erhard M, Simon JC et al. MALDI-TOF mass spectrometry – a rapid method for the identification of dermatophyte species. Med Mycol 2013; 51: 17–24.
-
Gräser Y. Species identification of dermatophytes by MALDI-TOF MS. Curr Fungal Infect Rep 2014; 8: 193–7.
10.1007/s12281-014-0189-7 Google Scholar
- Nasir S, Ralph N, O'Neill C et al. Trends in tinea capitis in an Irish pediatric population and a comparison of scalp brushings versus scalp scrapings as methods of investigation. Pediatr Dermatol 2014; 31: 622–3.
- Kane J, Summerbell R, Sigler L et al. Laboratory Handbook of Dermatophytes. Belmont, CA: Star Publications, 1997.
- Gräser Y, Fröhlich J, Presber W, de Hoog GS. Microsatellite markers reveal geographic population differentiation in Trichophyton rubrum . J Med Microbiol 2007; 56: 1058–65.
- Gräser Y, Czaika V, Ohst T. Diagnostische PCR für Dermatophyten – ein Überblick. J Dtsch Dermatol Ges 2012; 10: 721–6.
- Jensen RH, Arendrup MC. Molecular diagnosis of dermatophyte infections. Curr Opin Infect Dis 2012; 25: 126–34.
- Ohst T, Kupsch C, Graser Y. Detection of common dermatophytes in clinical specimens using a simple quantitative real-time TaqMan polymerase chain reaction assay. Br J Dermatol 2016; 174: 602–9.
- Paugam A, L'ollivier C, Viguié C et al. Comparison of real-time PCR with conventional methods to detect dermatophytes in samples from patients with suspected dermatophytosis. J Microbiol Methods 2013; 95: 218–22.
- Slowinska M, Rudnicka L, Schwartz RA et al. Comma hairs: a dermatoscopic marker for tinea capitis: a rapid diagnostic method. J Am Acad Dermatol 2008; 59: S77–9.
- Fuller LC, Barton RC, Mohd Mustapa MF et al. British Association of Dermatologists' guidelines for the management of tinea capitis 2014. Br J Dermatol 2014; 171: 454–63.
- Gupta AK, Cooper EA, Bowen JE. Meta-analysis: griseofulvin efficacy in the treatment of tinea capitis. J Drugs Dermatol 2008; 7: 369–72.
- Allen HB, Honig PJ, Leyden JJ et al. Selenium sulphide: adjunctive therapy for tinea capitis. Pediatrics 1982; 69: 81–3.
- Gupta AK, Hofstader SLR, Adam P et al. Tinea capitis: an overview with emphasis on management. Pediatr Dermatol 1999; 16: 171–89.
- Kobayashi M, Yamamote O, Asahi M. Kerion celsi in an infant treated with oral terbinafine. J Dermatol 2001; 28: 108–9.
- Ravenscroft J, Goodfield MJ, Evans EGV. Trichophyton tonsurans tinea capitis and tinea corporis: treatment and follow-up of four affected family members. Pediatr Dermatol 2000; 17: 407–9.
- Dragos V, Lunder M. Lack of efficacy of 6-weeks treatment with oral terbinafine for tinea capitis due to Microsporum canis . Pediatr Dermatol 1997; 14: 46–8.
- Hamm H, Schwinn A, Brautignam M et al. Short duration treatment with terbinafine for tinea capitis caused by Trichophyton or Microsporum species. Br J Dermatol 1999; 140: 480–2.
- Koumantaki E, Kakourou T, Rallis E et al. Doubled dose of oral terbinafine is required for Microsporum canis tinea capitis. Pediatr Dermatol 2001; 18: 339–42.
- Devliotou-Panagiotidou D, Koussidou-Eremondi TH. Efficacy and tolerability of 8 weeks’ treatment with terbinafine in children with tinea capitis caused by Microsporum canis: a comparison of three doses. J Eur Acad Dermatol Venereol 2004; 18: 155–9.
- Lipozencic J, Skerlev M, Orofino-Costa R et al. A randomized, double-blind, parallel-group, duration finding study of oral terbinafine and open, high-dose griseofulvin in children with tinea capitis due to Microsporum species. Br J Dermatol 2001; 146: 816–23.
- Elewski BE, Cáceres HW, DeLeon L et al. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials. J Am Acad Dermatol 2008; 59: 41–54.
- Legendre R, Esola-Macre J. Itraconazole in the treatment of tinea capitis. J Am Acad Dermatol 1990; 23: 559–60.
- Lopez-Gomez S, del Palacio A, van Cutsem J et al. Itraconazole versus griseofulvin in the treatment of tinea capitis: a double-blind randomized study in children. Int J Dermatol 1994; 33: 743–7.
- Abdel-Rahman SM, Powell DA, Nahata MC. Efficacy of itraconazole in children with Trichophyton tonsurans tinea capitis. J Am Acad Dermatol 1998; 38: 443–6.
- Ginter-Hanselmayer G, Smolle J, Gupta A. Itraconazole in the treatment of tinea capitis caused by Microsporum canis: experience in a large cohort. Pediatr Dermatol 2004; 21: 499–502.
- Binder B, Richtig E, Weger W et al. Tinea capitis in early infancy treated with itraconazole: a pilot study. J Eur Acad Dermatol Venereol 2009; 23: 1161–3.
- Gupta AK, Alexis ME, Raboobee N et al. Itraconazole pulse therapy is effective in the treatment of tinea capitis: an open multicentre study. Br J Dermatol 1997; 137: 251–4.
- Gupta AK, Hofstader SL, Summerbell RC et al. Treatment of tinea capitis with itraconazole capsule pulse therapy. J Am Acad Dermatol 1998; 39: 216–19.
- Gupta AK, Adam P, Hofstader SL et al. Intermittent short duration therapy with fluconazole is effective for tinea capitis. Br J Dermatol 1999; 141: 304–6.
- Gupta AK, Dlova N, Taborda P et al. Once weekly fluconazole is effective in the treatment of tinea capitis: a prospective, multicentre study. Br J Dermatol 2000; 142: 965–8.
- Foster KW, Friedlander SF, Panzer H et al. A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis. J Am Acad Dermatol 2005; 53: 798–809.
- Gupta AK, Adam P, Dlova N et al. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole and fluconazole. Pediatr Dermatol 2001; 18: 433–8.
- Gray RM, Champagne C, Waghorn D et al. Management of a Trichophyton tonsurans outbreak in a day-care center. Pediatr Dermatol 2015; 32: 91–6.
-
Evans EGV, James IGV, Joshipura RC. One week treatment of tinea corporis and tinea cruris with terbinafine (Lamisil) 1% cream: a placebo controlled study. J Dermatol Treat 1992; 3: 181–4.
10.3109/09546639209088719 Google Scholar
- Korting HC, Kiencke P, Nelles S, Rychlik R. Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis. Am J Clin Dermatol 2007; 8: 357–64.
- Ortonne JP, Korting HC, Viguié-Vallanet C et al. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study. J Eur Acad Dermatol Venereol 2006; 20: 1307–13.
- Hay RJ, McGregor JM, Ryatt KS et al. A comparison of 2 weeks terbinafine 250 mg/day with 4 weeks itraconazole 100 mg/day in plantar type tinea pedis. Br J Dermatol 1995; 132: 604–8.
- Gupta AK, Paquet M. Systemic antifungals to treat onychomycosis in children: a systematic review. Pediatr Dermatol 2013; 30: 294–302.
- Gupta AK, Fleckman P, Baran R. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis. J Am Acad Dermatol 2000; 43(4 suppl): S70–80.
- Baran R, Sigurgeirsson B, Berker D et al. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapie with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement. Br J Dermatol 2007; 157: 149–57.
References
- Veron S. Memoire sur le muguet. Arch Gen Med 1835; 8: 466.
- Langenbeck B. Auffindung von Pilzen aus der Schleimhaut der Speiseröhre einer Typhus-Leiche. Neue Not Geb Natur-U Helik (Froriep) 1839; 12: 145–7.
-
Bennett JH. On the parasitic vegetable structures found growing in living animals. Trans Roy Soc Edin 1844; 15: 277–94.
10.1017/S0080456800029963 Google Scholar
- Zopf W. Die Pilze in morphologischer, physiologischer, biologischer und systematischer Richtung. Breslau: Trewendt, 1890.
- Berkhout CM. De Schimmelgeschlachten Monilia, Oidium oospora en Torula. Dissertation. University of Utrecht, 1923.
- Al-Ahmad A, Auschill TM, Dakhel R et al. Prevalence of Candida albicans and Candida dubliniensis in caries-free and caries-active children in relation to the oral microbiota – a clinical study. Clin Oral Investig 2016; 20: 1963–71.
- Odds FC. Candida and Candidosis, 2nd edn. London: Baillière Tindall, 1988.
- Kashbur IM, Ayliffe GAJ, George RH. The survival of Candida albicans in moist and dry environments. J Hosp Infect 1980; 1: 349–51.
- Polke M, Hube B, Jacobsen ID. Candida survival strategies. Adv Appl Microbiol 2015; 91: 139–235.
- Saiman L, Ludington E, Dawson JD et al. The National Epidemiology of Mycoses Study Group. Risk factors for Candida species colonisation of neonatal intensive care unit patients. Pediatr Infect Dis J 2001; 20: 1119–24.
- Gagneur A, Sizun J, Vernotte E et al. Low rate of Candida parapsilosis-related colonisation and infection in hospitalised pre-term infants: a one-year prospective study. J Hosp Infect 2001; 48: 193–7.
- Netea MG, Joosten LA, van der Meer JW et al. Immune defence against Candida fungal infections. Nat Rev Immunol 2015; 15: 630–42.
- Dixon PN, Warin RP, English MP. Alimentary Candida albicans and napkin rashes. Br J Dermatol 1972; 86: 458–62.
- Lehner T. Classification and clinico-pathological features of Candida infections in the mouth. In: H Winner, R Hurley (eds) Symposium on Candida Infections. Edinburgh: Livingstone, 1966: 119–37.
- Katz MH, Mastrucci MT, Leggott PJ et al. Prognostic significance of oral lesions in children with perinatally acquired human immunodeficiency virus infections. Am J Dis Child 1993; 147: 45–8.
- Jabra-Rizk MA, Falkler WA, Enwonwu CO. Prevalence of yeast among children in Nigeria and the United States. Oral Microbiol Immunol 2001; 16: 383–5.
- Brown DM, Jabra-Rizk MA, Falkler WA et al. Identification of Candida dubliniensis in a study of HIV-seropositive pediatric dental patients. Pediatr Dent 2000; 22: 234–8.
- Muller FM, Weig M, Peter J et al. Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis. J Antimicrob Chemother 2000; 46: 338–40.
- Pelletier R, Peter J, Gonzalez C et al. Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations. J Clin Microbiol 2000; 38: 1563–8.
- Lehner T, Ward RG. Iatrogenic oral candidosis. Br J Dermatol 1970; 83: 161–6.
- Klunk C, Domingues E, Wiss K. An update on diaper dermatitis. Clin Dermatol 2014; 32: 477–87.
- Rebora A, Leyden JJ. Napkin (diaper) dermatitis and gastrointestinal carriage of Candida albicans . Br J Dermatol 1981; 105: 551–5.
- Leyden JJ, Kligman AM. The role of microorganisms in diaper dermatitis. Arch Dermatol 1978; 114: 56–9.
- Dixon PN, Warin RP, English MP. The role of Candida albicans infection in napkin rashes. BMJ 1969; 2: 23–7.
- Raimer SS, Petrusick TW. Superficial fungal infections in children. Dermatol Clin 1984; 2: 57–65.
- Plantin P, Jouan N, Calligaris C et al. Onychomycosis in a newborn due to Candida albicans with neonatal infection. Ann Dermatol Vénéréol 1992; 119: 213–15.
- Abraham Z, Sujov P, Blazer S et al. Candida onychomycosis in a preterm infant. Mykosen 1986; 29: 357–9.
- Chapel TA, Gagliardi C, Nichols W. Congenital cutaneous candidosis. J Am Acad Dermatol 1982; 6: 926–8.
- Whyte RK, de Hussain Z, Sa D. Antenatal infections with Candida species. Arch Dis Child 1982; 57: 528–35.
- Darmstadt GL, Dinulos JG, Miller Z. Congenital cutaneous candidiasis: clinical presentation, pathogenesis, and management guidelines. Pediatrics 2000; 105: 438–44.
- Lanternier F, Cypowyj S, Picard C et al. Primary immunodeficiencies underlying fungal infections. Curr Opin Pediatr 2013; 25: 736–47.
- Sparber F, LeibundGut-Landmann S. Interleukin 17-mediated host defense against Candida albicans. Pathogens 2015; 4: 606–19.
- Shama SK, Kirkpatrick CH. Dermatophytoses in patients with chronic mucocutaneous candidiasis. J Am Acad Dermatol 1980; 2: 285–94.
- Trtkova J, Raclavsky V. Molecular-genetic approaches to identification and typing of pathogenic Candida yeasts. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2006; 150: 51–61.
- Koehler P, Cornely OA. Contemporary strategies in the prevention and management of fungal infections. Infect Dis Clin North Am 2016; 30: 265–75.
- Cohen-Wolkowiez M, Moran C, Benjamin DK Jr, Smith PB. Pediatric antifungal agents. Curr Opin Infect Dis 2009; 22: 553–8.
- Ameen M, Lear JT, Madan V et al. British Association of Dermatologists' guidelines for the management of onychomycosis 2014. Br J Dermatol 2014; 171: 937–58.
References
- Theelen B, Cafarchia C, Gaitanis G et al. Malassezia ecology, pathophysiology, and treatment. Med Mycol 2018; 56(suppl 1): S10–25.
- Boekhout T, Guého E, Mayser P, Velegraki A. Malassezia and the Skin. New York: Springer, 2009.
- Eichstedt CF. Pilzbildung in der Pityriasis versicolor. Froriep's Neue Notizen aus dem Gebiete der Natur- und Heilkunde 1846; 853: 270–1.
- Sluyter T. De vegetabilibus organismi animalis parasitis ac de novo epiphyto in pityriasi versicolore obvio. Inaugural address. Berlin: G. Schade, 1847.
- Robin C. Histoire Naturelle des Vegetaux Parasites. Paris: Baillière, 1853.
- Malassez L. Note sur le champignon de la pelade. Arch Physiol 1874; 11: 203–12.
- Baillon EH. Traite de Botanique Medicale Cryptogamique. Paris: Octave Doin Editeur, 1889: 234–5.
- Castellani A, Chalmers AJ. Manual of Tropical Medicine, 2nd edn. London: Baillière Tindall and Cox, 1913.
- Sabouraud R. Maladies des cuir chevelu. 11 Les maladies desquamatives. Paris: Masson, 1904.
-
Kraus A. Uber das Wesen des sogenannten Unnaschen Flaschenbazillus. Arch Dermatol Syphil 1913; 106: 723–6.
10.1007/BF01979686 Google Scholar
- Benham RW. The cultural characteristics of Pityrosporum ovale: a lipophilic fungus. J Invest Dermatol 1939; 2: 187–203.
- Panja G. The Malassezia of the skin, their cultivation morphology and species [trans.]. 7th Cong Far East Assoc Trop Med 1927; 2: 442–56.
- Gordon M. Lipophilic yeast-like organisms associated with tinea versicolor. J Invest Dermatol 1951; 17: 267–72.
- Keddie LM, Shadomy S. Etiological significance of Pityrosporum orbiculare in tinea versicolor. Sabouraudia 1963; 3: 21–5.
- Sternberg TH, Keddie FM. Immunofluorescence studies in tinea versicolor. Arch Dermatol 1961; 84: 999–1003.
- Yarrow D, Ahearn DG. Genus 7. Malassezia Baillon. In: NJW Kreger-van Rij (ed.) The Yeasts. A Taxonomic Study, 3rd edn. Amsterdam: Elsevier Science, 1984: 882–5.
- Simmons RB, Gueho E. A new species of Malassezia . Mycol Res 1990; 94: 1146–9.
- Gueho E, Midgley G, Guillot J. The genus Malassezia with description of four new species. Antonie Leeuwenhoek 1996; 69: 337–55.
- Roberts SOB. Pityriasis: a clinical and mycological investigation. Br J Dermatol 1969; 81: 315–26.
- Roberts SOB. Pityrosporum orbiculare incidence and distribution on clinically normal skin. Br J Dermatol 1969; 81: 264–9.
- Crespo-Erchiga V, Ojeda A, Vera A et al. Malassezia globosa as the causative agent of pityriasis versicolor. Br J Dermatol 2000; 143: 799–803.
- Gupta AK, Kohli Y, Summerbell RC et al. Quantitative culture of Malassezia species from different body sites of individuals with or without dermatoses. Med Mycol 2001; 39: 243–51.
- Nakabayashi A, Sei Y, Guillot J. Identification of Malassezia species isolated from patients with seborrheic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med Mycol 2000; 38: 337–41.
- Wu G, Zhao H, Li C et al. Genus-wide comparative genomics of Malassezia delineates its phylogeny, physiology, and niche adaptation on human skin. PLoS Genet 2015; 11: e1005614.
- Faergemann J, Fredriksson T. Age incidence of Pityrosporum orbiculare on human skin. Acta Dermatol Venereol (Stockh) 1980; 60: 531–3.
- Thianprasit M, Thagerngpol K. Pityriasis versicolor. In: F Gatti, C Vroey (eds) Human Mycoses in Tropical Countries. Bologna: Quaderni di Cooperazione Sanitaria, 1991: 63–9.
- Powell DA, Hayes J, Durrell DE et al. Malassezia furfur skin colonization of infants hospitalized in intensive care units. J Pediatr 1987; 111: 217–20.
- Ashbee HR, Leck AK, Puntis JWL et al. Skin colonisation by Malassezia in neonates and infants. Infect Cont Hosp Epidemiol 2002; 23: 212–16.
- Noble WC, Midgley G. Scalp carriage of Pityrosporum species: the effect of physiological maturity, sex and race. Sabouraudia 1978; 16: 229–32.
- Bergbrant IM, Broberg A. Pityrosporum ovale. Culture from the forehead of healthy children. Acta Dermatol Venereol (Stockh) 1994; 74: 260–1.
- Crespo-Erchiga V, Florencio VD. Malassezia yeasts and pityriasis versicolor. Curr Opin Infect Dis 2006; 19: 139–47.
- Gupta AK, Batra R, Bluhm R et al. Pityriasis versicolor. Dermatol Clin 2003; 21: 413–42.
-
Canizares O, Shatin H, Kellert AJ. Cushing's syndrome and dermatomycosis. Arch Dermatol 1959; 80: 701–12.
10.1001/archderm.1959.01560240057007 Google Scholar
- He SM, Du WD, Yang S et al. The genetic epidemiology of tinea versicolor in China. Mycoses 2008; 51: 55–62.
- Zuther K, Mayser P, Hettwer U et al. The tryptophan aminotransferase Tam1 catalyses the single biosynthetic step for tryptophan-dependent pigment synthesis in Ustilago maydis . Mol Microbiol 2008; 68: 152–72.
- Mayser P, Rieche I. Rapid reversal of hyperpigmentation in pityriasis versicolor upon short term topical cycloserine application. Mycoses 2009; 52: 541–3.
- Xu J, Saunders CW, Hu P et al. Dandruff-associated Malassezia genomes reveal convergent and divergent virulence traits shared with plant and human fungal pathogens. Proc Natl Acad Sci U S A 2007; 104: 18730–5.
- Michalowski R, Rodziewicz H. Pityriasis versicolor in children. Br J Dermatol 1963; 75: 397–400.
- Miskeen AK, Kelkor SS, Shroff HJ. Pityriasis versicolor in children. Indian J Dermatol Venereol Leprol 1984; 50: 144–6.
- Terragni L, Lasagni A, Oriani A et al. Pityriasis versicolor in the paediatric age. Pediatr Dermatol 1991; 8: 9–12.
- Bouassida S, Boudaya S, Ghorbel R et al. Pityriasis versicolor in children: a retrospective study of 164 cases. Ann Dermatol Venereol 1998; 125: 581–4.
- Pontasch MJ, Kyanko ME, Brobell RT. Tinea versicolor of the face in black children in a temperate region. Cutis 1989; 43: 81–4.
- Jena DK, Sengupta S, Dwari BC, Ram MK. Pityriasis versicolor in the pediatric age group. Indian J Dermatol Venereol Leprol 2005; 71: 259–61.
- Wyre HW, Johnston WT. Neonatal pityriasis versicolor. Arch Dermatol 1981; 117: 752–3.
- Thoma W, Krämer HJ, Mayser P. Pityriasis versicolor alba. J Eur Acad Dermatol Venereol 2005; 19: 147–52.
- Midgley G. The lipophilic yeasts: state of the art and prospects. Med Mycol 2000; 38(suppl 1): 9–16.
- Krisanty RI, Bramono K, Made Wisnu I. Identification of Malassezia species from pityriasis versicolor in Indonesia and its relationship with clinical characteristics. Mycoses 2009; 52: 257–62.
- De Almeida Jr H, Mayser P. Absence of sunburn in lesions of pityriasis versicolor alba. Mycoses 2006; 49: 516.
- Hu SW, Bigby M Pityriasis versicolor: a systematic review of interventions. Arch Dermatol 2010; 146: 1132–40.
- Back O, Faergemann J, Hornqvist R. Pityrosporum folliculitis: a common disease of the young and middle aged. J Am Acad Dermatol 1985; 12: 56–61.
- Jacinto-Jamora S, Tamesis J, Katigbak ML. Pityrosporum folliculitis in the Philippines: diagnosis, prevalence and management. J Am Acad Dermatol 1991; 24: 693–6.
- Hill MK, Goodfield MJD, Rodgers FG et al. Skin surface electron microscopy in Pityrosporum folliculitis. Arch Dermatol 1990; 126: 181–4.
- Akaza N, Akamatsu H, Sasaki Y, Malassezia folliculitis is caused by cutaneous resident Malassezia species. Med Mycol 2008; 23: 1–7.
- Devred D, Agache P, Barale T et al. Pityrosporum et dermite seborrheique du nourrisson. Ann Dermatol Vénéréol 1985; 112: 211.
- Ruiz-Maldonado R, Lopez-Matinez R, Perez Chavarria EL et al. Pityrosporum ovale in infantile seborrhoeic dermatitis. Pediatr Dermatol 1989; 6: 16–20.
- Broberg A, Faergemann J. Infantile seborrhoeic dermatitis and Pityrosporum ovale . Br J Dermatol 1989; 120: 359–62.
- Nakabayashi A, Sei Y. Relationship between Malassezia yeast and infantile seborrhoeic dermatitis. Nippon Ishinkin Gakkai Zasshi 2001; 42: 218–20.
- Taïeb A, Legrain V, Palmier C et al. Topical ketoconazole for infantile seborrhoeic dermatitis. Dermatologica 1990; 181: 26–32.
- Aractingi S, Cadranel S, Reygagne P et al. Pustulose neonatale induite par Malassezia furfur . Ann Dermatol Venereol 1991; 118: 856–8.
- Rapelanoro R, Mortureux P, Couprie B et al. Neonatal Malassezia furfur pustulosis. Arch Dermatol 1996; 132: 190–3.
- Niamba P, Weill FX, Sarlangue J et al. Is common neonatal cephalic pustulosis (neonatal acne) triggered by Malassezia sympodialis? Arch Dermatol 1998; 134: 995–8.
- Bernier V, Weill FX, Hirigoyen V et al. Skin colonisation by Malassezia species in neonates. A prospective study and relationship with neonatal cephalic pustulosis. Arch Dermatol 2002; 138: 215–18.
- Bergman JN, Eichenfield LF. Neonatal acne and cephalic pustulosis. Is Malassezia the whole story? Arch Dermatol 2002; 138: 255–7.
- Ayhan M, Sancak B, Karaduman A et al. Colonization of neonate skin by Malassezia species: relationship with neonatal cephalic pustulosis. J Am Acad Dermatol 2007; 57: 1012–18.
- Darabi K, Hostetler SG, Bechtel MA, Zirwas M.The role of Malassezia in atopic dermatitis affecting the head and neck of adults. J Am Acad Dermatol 2009; 60: 125–36.
- Schmid-Grendelmeier P, Scheynius A, Crameri R. The role of sensitization to Malassezia sympodialis in atopic eczema. Chem Immunol Allergy 2006; 91: 98–109.
- Takahata Y, Sugita T, Kato H et al. Cutaneous Malassezia flora in atopic dermatitis differs between adults and children. Br J Dermatol 2007; 157: 1178–82.
- Lange L, Alter N, Keller T et al. Sensitization to Malassezia in infants and children with atopic dermatitis: prevalence and clinical characteristics. Allergy 2008; 63: 486–7.
-
Marcon MJ, Powell DA. Human infections due to Malassezia spp. Clin Microbiol Rev 1992; 2: 101–19.
10.1128/CMR.5.2.101 Google Scholar
- Tragiannidis A, Bisping G, Koehler G, Groll AH. Minireview: Malassezia infections in immunocompromised patients. Mycoses 2010; 53: 187–95.
- Chang HJ, Miller H, Watkins N et al. An epidemic of Malassezia pachydermatis in an intensive care nursery associated with colonization of health care workers’ pet dogs. N Engl J Med 1998; 338: 706–11.
- Chryssanthou E, Broberger U, Petrini B. Malassezia pachydermatis fungaemia in a neonatal intensive care unit. Acta Paediatr 2001; 90: 323–7.
References
- Gueho E, Improvisi L, De Hoog GS et al. Trichosporon on humans: a practical account. Mycoses 1994; 37: 3–10.
- Chagas-Neto TC, Chaves GM, Colombo AL. Update on the genus Trichosporon . Mycopathologia 2008; 166: 121–32.
- Kalter DC, Tschen JA, Cernock PL et al. Genital white piedra: epidemiology, microbiology and therapy. J Am Acad Dermatol 1986; 14: 982–93.
- Therizol-Ferly M, Kombila M, Gomez de Diaz M et al. White piedra and Trichosporon species in equatorial Africa. I. History and clinical aspects: an analysis of 449 superficial inguinal specimens. Mycoses 1994; 37: 249–53.
- Coimbra CEA, Santos RV. Black piedra among the Zoro indians from Amazonia (Brazil). Mycopathologia 1989; 107: 57–60.
- Gip L. Terbinafine for black piedra. Lancet 1993; 341: 1164.
-
Palmer SR, Bass JW, Mandojana R et al. Tinea nigra palmaris and plantaris: a black fungus producing black spots on the palms and soles. Pediatr Infect Dis 1989; 8: 49–50.
10.1097/00006454-198901000-00012 Google Scholar
- Bonifaz A, Badali H, de Hoog GS et al. Tinea nigra by Hortaea werneckii, a report of 22 cases from Mexico. Stud Mycol 2008; 61: 77–82.
- Machouart M, Menir P, Helenon R et al. Scytalidium and scytalidiosis: what's new in 2012? J Mycol Med 2013; 23: 40–6.
- Ruíz-Cendoya M, Madrid H, Pastor FJ et al. Development of murine models of disseminated infection by Neoscytalidium dimidiatum. Med Mycol 2010; 48: 681–6.
- Oyeka CA, Gugnani HC. Skin infections due to Hendersonula toruloidea, Scytalidium hyalinum, Fusarium solani and dermatophytes in cement factory workers. J Mycol Med 1992; 2: 197–201.
- Perera J, Perera C. Fungal skin infections in a paediatric dermatology clinic. Ceyl Med J 1993; 38: 75–7.
-
Elewski BE, Greer DL.
Hendersonula toruloidea and Scytalidium hyalinum
. Arch Dermatol 1991; 172: 1041–4.
10.1001/archderm.1991.01680060115016 Google Scholar
- Frankel DH, Rippon JW. Hendersonula toruloidea infection in man. Mycopathologia 1989; 105: 175–86.
- Hay RJ, Moore MK. Clinical features of superficial fungal infections caused by Hendersonula toruloidea and Scytalidium hyalinum . Br J Dermatol 1984; 110: 677–83.
- Midgley G, Moore MK, Cook JC et al. Mycology of nail disorders. J Am Acad Dermatol 1994; 31: S68–74.
- James JE, Santhanam J, Lee MC et al. In vitro antifungal susceptibility of Neoscytalidium dimidiatum clinical isolates from Malaysia. Mycopathologia 2017; 182: 305–13.